Clinical Trials Directory

Trials / Unknown

UnknownNCT02140489

Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin

An Open-label, Randomized, Single-dose Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin in Healthy Male Volunteers

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Hanmi Pharmaceutical Company Limited · Industry
Sex
Male
Age
19 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the drug-drug interaction between amlodipine/losartan and rosuvastatin in healthy male volunteers.

Conditions

Interventions

TypeNameDescription
DRUGamosartan
DRUGrosuvastatin
DRUGamosartan and rosuvastatin

Timeline

Start date
2014-02-01
Primary completion
2014-05-01
Completion
2014-08-01
First posted
2014-05-16
Last updated
2014-05-16

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02140489. Inclusion in this directory is not an endorsement.